Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Axitinib × Clear all

NCT03472560 2024-04-09

A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)

Phase 2 Terminated

61 enrolled 26 charts

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT04459663 2020-07-07

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00600821 2013-11-08

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Phase 2 Completed

118 enrolled 12 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00735904 2013-01-03

Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

38 enrolled 9 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00386555 2012-08-09

A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT00094094 2012-06-26

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

32 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms